Figure 3
From: TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
TMED3 promotes HCC metastasis in vivo.
(A) Lung metastases that developed after injecting HepG2 cell lines in the lateral tail vein were imaged using the IVIS Imaging System. Representative luciferase signals captured in each group (n = 9) at initial injection and after 42 days are shown. The statistical analysis is shown in (C), n = 9, mean ± SD, the Student’s t test, *p < 0.05 versus GFP control. (B) Representative imaged of H&E-stained lung metastatic loci from each group in (A). The statistical analysis is shown in (D).
